- Home
- KALV vs CARS Comparison
KALV vs CARS Comparison
Compare KALV & CARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALV
- CARS
- Stock Information
- Founded
- KALV N/A
- CARS 1998
- Country
- KALV United States
- CARS United States
- Employees
- KALV N/A
- CARS N/A
- Industry
- KALV Biotechnology: Pharmaceutical Preparations
- CARS Motor Vehicles
- Sector
- KALV Health Care
- CARS Consumer Discretionary
- Exchange
- KALV Nasdaq
- CARS Nasdaq
- Market Cap
- KALV 796.4M
- CARS 815.4M
- IPO Year
- KALV N/A
- CARS 2017
- Fundamental
- Price
- KALV $11.08
- CARS $10.42
- Analyst Decision
- KALV Strong Buy
- CARS Strong Buy
- Analyst Count
- KALV 8
- CARS 5
- Target Price
- KALV $26.43
- CARS $17.90
- AVG Volume (30 Days)
- KALV 1.5M
- CARS 890.6K
- Earning Date
- KALV 12-04-2025
- CARS 11-06-2025
- Dividend Yield
- KALV N/A
- CARS N/A
- EPS Growth
- KALV N/A
- CARS 69.36
- EPS
- KALV N/A
- CARS 0.63
- Revenue
- KALV $1,426,000.00
- CARS $717,845,000.00
- Revenue This Year
- KALV N/A
- CARS $2.52
- Revenue Next Year
- KALV $209.38
- CARS $2.93
- P/E Ratio
- KALV N/A
- CARS $16.42
- Revenue Growth
- KALV N/A
- CARS 0.68
- 52 Week Low
- KALV $7.30
- CARS $9.56
- 52 Week High
- KALV $17.28
- CARS $20.47
- Technical
- Relative Strength Index (RSI)
- KALV 38.81
- CARS 31.29
- Support Level
- KALV $10.75
- CARS $10.25
- Resistance Level
- KALV $12.23
- CARS $10.92
- Average True Range (ATR)
- KALV 0.62
- CARS 0.49
- MACD
- KALV -0.01
- CARS -0.11
- Stochastic Oscillator
- KALV 22.25
- CARS 14.74
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.
About CARS Cars.com Inc.
Cars.com Inc is an online destination for buying and selling new and used vehicles. It is an audience-driven technology company empowering the automotive industry. The company brands include Dealer Inspire, DealerRater, FUEL, Accu-Trade, PickupTrucks.com, CreditIQ, and NewCars.com., websites directed towards different consumer segments.